0000899243-22-007496.txt : 20220223
0000899243-22-007496.hdr.sgml : 20220223
20220223200012
ACCESSION NUMBER: 0000899243-22-007496
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rivera Victor
CENTRAL INDEX KEY: 0001876623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 22665842
MAIL ADDRESS:
STREET 1: 210 BROADWAY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-18
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001876623
Rivera Victor
C/O THESEUS PHARMACEUTICALS, INC.
245 MAIN STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Stock Option (right to buy)
11.21
2022-02-18
4
A
0
130000
0.00
A
2032-02-17
Common Stock
130000
130000
D
The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 18, 2023 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
/s/ Bradford Dahms - Attorney-in-Fact
2022-02-23